查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1936939

全球过敏免疫疗法市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Allergy Immunotherapy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年，过敏免疫疗法的市场规模将从 2025 年的 20.5 亿美元成长至 45.7 亿美元，2026 年至 2034 年的复合年增长率为 9.28%。

随着全球过敏性疾病盛行率持续上升，过敏免疫疗法市场预计将迎来显着成长。人们对免疫疗法在过敏管理中长期益处的认识不断提高，推动了患者和医疗服务提供者对这种治疗方案的兴趣日益浓厚。免疫疗法技术的进步，例如皮下和舌下给药，正在推动市场发展，与传统过敏治疗方法相比，这些技术更有效、更方便。随着对过敏反应潜在机制研究的不断深入，标靶治疗的开发有望进一步提高治疗效果和患者依从性。

技术创新在塑造过敏免疫疗法市场的未来前景方面发挥着至关重要的作用。个人化医疗方法（即根据个别患者情况客製化治疗方案）的整合正在不断推进。这种向精准医疗的转变有望改善治疗效果、减少副作用并提高患者满意度。此外，生物製药和单株抗体的出现正在改变过敏治疗的格局，为治疗严重过敏反应和慢性疾病开闢了新的途径。随着这些先进治疗方法获得监管部门的核准，其应用预计将加速，进一步推动市场成长。

此外，过敏免疫疗法市场也受惠于预防医学和早期疗育策略日益受到重视。随着医疗保健系统优先采用积极主动的过敏管理方法，对免疫疗法的需求预计将会增加。旨在让患者了解免疫疗法益处的公共宣传宣传活动和教育倡议也将促进市场扩张。总之，在技术进步、个人化治疗方案以及旨在改善患者疗效的合作努力的推动下，过敏免疫疗法市场有望显着成长。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

第四章 全球过敏免疫疗法市场：依治疗类型划分

  • 市场分析、洞察与预测
  • 皮下免疫疗法
  • 舌下免疫疗法

第五章：全球过敏免疫疗法市场：按类型划分

  • 市场分析、洞察与预测
  • 药片
  • 降低

第六章 全球过敏免疫疗法市场：依过敏类型划分

  • 市场分析、洞察与预测
  • 过敏性鼻炎
  • 过敏性气喘
  • 其他的

第七章 全球过敏免疫疗法市场：依通路划分

  • 市场分析、洞察与预测
  • 医院药房
  • 零售药房
  • 网路药房

第八章 全球过敏免疫疗法市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第九章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • DMK Pharmaceuticals
    • ALK-AbellAfA3 A/S
    • Allergy Therapeutics
    • ASIT Biotech
    • Circassia
    • DVB Technologies SA
    • DESENTUM OY
    • HAL Allergy BV
    • HollisterStier Allergy
    • LETIPharma
简介目录
Product Code: VMR11213853

The Allergy Immunotherapy Market size is expected to reach USD 4.57 Billion in 2034 from USD 2.05 Billion (2025) growing at a CAGR of 9.28% during 2026-2034.

The allergy immunotherapy market is set for remarkable growth as the prevalence of allergic conditions continues to rise globally. With increasing awareness of the long-term benefits of immunotherapy in managing allergies, patients and healthcare providers are increasingly turning to this treatment option. The market is being driven by advancements in immunotherapy techniques, including subcutaneous and sublingual methods, which offer more effective and patient-friendly alternatives to traditional allergy treatments. As research continues to unveil the underlying mechanisms of allergic responses, the development of targeted therapies is expected to enhance treatment efficacy and patient compliance.

Technological innovations are playing a crucial role in shaping the future of the allergy immunotherapy market. The integration of personalized medicine approaches, where treatments are tailored to individual patient profiles, is gaining traction. This shift towards precision medicine is expected to improve treatment outcomes and minimize adverse effects, thereby increasing patient satisfaction. Additionally, the emergence of biologics and monoclonal antibodies is revolutionizing the landscape of allergy treatment, providing new avenues for managing severe allergic reactions and chronic conditions. As these advanced therapies gain regulatory approval, their adoption is likely to accelerate, further propelling market growth.

Furthermore, the allergy immunotherapy market is benefiting from a growing emphasis on preventive healthcare and early intervention strategies. As healthcare systems prioritize proactive approaches to managing allergies, the demand for immunotherapy is expected to rise. Public awareness campaigns and educational initiatives aimed at informing patients about the benefits of immunotherapy will also contribute to market expansion. In summary, the allergy immunotherapy market is poised for significant growth, driven by technological advancements, personalized treatment approaches, and a collective commitment to improving patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment Type

  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

By Type

  • Tablets
  • Drops

By Allergy Type

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

COMPANIES PROFILED

  • DMK Pharmaceuticals, ALKAbell AS, Allergy Therapeutics, ASIT Biotech, Circassia, DVB Technologies SA, DESENTUM OY, HAL Allergy BV, HollisterStier Allergy, LETIPharma

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Treatment Type
  • 4.2. Subcutaneous Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Sublingual Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Drops Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY ALLERGY TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Allergy Type
  • 6.2. Allergic Rhinitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Allergic Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Distribution Channel
  • 7.2. Hospital Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Retail Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Online Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Treatment Type
    • 8.2.2 By Type
    • 8.2.3 By Allergy Type
    • 8.2.4 By Distribution Channel
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Treatment Type
    • 8.3.2 By Type
    • 8.3.3 By Allergy Type
    • 8.3.4 By Distribution Channel
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Treatment Type
    • 8.4.2 By Type
    • 8.4.3 By Allergy Type
    • 8.4.4 By Distribution Channel
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Treatment Type
    • 8.5.2 By Type
    • 8.5.3 By Allergy Type
    • 8.5.4 By Distribution Channel
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Treatment Type
    • 8.6.2 By Type
    • 8.6.3 By Allergy Type
    • 8.6.4 By Distribution Channel
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ALLERGY IMMUNOTHERAPY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 DMK Pharmaceuticals
    • 10.2.2 ALK-AbellAfA3 A/S
    • 10.2.3 Allergy Therapeutics
    • 10.2.4 ASIT Biotech
    • 10.2.5 Circassia
    • 10.2.6 DVB Technologies SA
    • 10.2.7 DESENTUM OY
    • 10.2.8 HAL Allergy B.V
    • 10.2.9 HollisterStier Allergy
    • 10.2.10 LETIPharma